-
Fibroblast growth factor 10 ameliorates renal ischaemia-reperfusion injury by attenuating mitochondrial damage
Author: Yu, Lixia; Yi, Xiaojiao; Yu, Cailong; Wang, Fugen; Tan, Xiaohua
Journal: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2023; Vol. 50, Issue 1, pp. 59-67. DOI: 10.1111/1440-1681.13724
-
A gain of function ryanodine receptor 2 mutation (R1760W-RyR2) in catecholaminergic polymorphic ventricular tachycardia
Author: Li, Siyuan; Lv, Tingting; Yang, Jing; Li, Kun; Yang, Ying; Zhang, Ping
Journal: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2023; Vol. 50, Issue 1, pp. 39-49. DOI: 10.1111/1440-1681.13722
-
Molecular insight of p53/Sp1/MUC5AC axis in the tumorigenesis and progression of lung adenocarcinoma
Author: Zhang, Jing; He, Wenjuan; Hu, Xiangying; Fang, Xia; Wang, Guosheng; Tang, Rongjuan; Zhang, Ping; Li, Qiang
Journal: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2023; Vol. 50, Issue 1, pp. 28-38. DOI: 10.1111/1440-1681.13720
-
SIRT1 targeted by miR-211-5p regulated proliferation and apoptosis of Dex-treated growth plate chondrocytes via mediating SOX2
Author: Cheng, Deliang; Zhang, Lijun; Liang, Xiaoju
Journal: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2023; Vol. 50, Issue 1, pp. 50-58. DOI: 10.1111/1440-1681.13721
-
Angiotensin-receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT-5A pathway
Author: Feng, Ronghua; Wan, Jinjie; He, Yongsheng; Gong, Hui; Xu, Zeqin; Feng, Jiugeng
Journal: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2023; Vol. 50, Issue 1, pp. 19-27. DOI: 10.1111/1440-1681.13715
-
Dapagliflozin modulates the faecal microbiota after myocardial infarction in non-diabetic mice
Author: Li, Zhongming; Wang, Kai; Ding, Yinzhang; Ma, Wenjie; Sun, Yan; Liu, Xianling; Qian, Lijun; Li, Yansong; Hong, Jian; Xu, Di
Journal: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2023; Vol. 50, Issue 1, pp. 68-81. DOI: 10.1111/1440-1681.13727
-
Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII-induced angiogenesis by interacting with IRE1 in its active conformation
Author: Fan, Fangtian; Liu, Fang; Shen, Peiliang; Tao, Li; Zhang, Hongjiang; Wu, Hongyan
Journal: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2023; Vol. 50, Issue 1, pp. 82-95. DOI: 10.1111/1440-1681.13726
-
Ulinastatin affects focal cerebral ischemia-reperfusion injury via SOCS1-mediated JAK2/STAT3 signalling pathway
Author: Chen, Xiaoxi; Li, Peng; Huang, Renming; Zhang, Juan; Ouyang, Xingzhi; Tan, Dianxiang
Journal: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2023; Vol. 50, Issue 1, pp. 107-116. DOI: 10.1111/1440-1681.13731
